Blog

Accelerating Drug Development with Zebrafish Models

Exploring the Benefits of Zebrafish Model in Modern Research

Advancing Drug Discovery with Zebrafish High-Content Screening

Leveraging Zebrafish for Reduction, Refinement, and Replacement in Preclinical Studies

Identifying Successfully Injected Embryos With Fluorescence

How To Do A Microinjection of Zebrafish Embryos?

Proven Techniques for Successful Zebrafish Reproduction and Embryo Collection

Understanding Shared Genes and Their Impact on Human Medicine

What Does Zebrafish Eat? Balancing Nutrition and Convenience with Live and Dry Food

Essential Zebrafish Husbandry Practices for Effective Tank Cleaning and Disinfection

Best Practices for Zebrafish Husbandry: Monitoring Health and Maintaining Rack Systems

Best Practices for Long-Term Zebrafish Care and Husbandry

A Step-by-Step Guide to Establishing a Thriving Zebrafish Colony

Essential Water Quality Tips for Healthy and Thriving Zebrafish

Temperature, pH, Conductivity and Density Guidelines for Zebrafish Husbandry

Understanding Zebrafish Biology and Behavior in Research

From Ornamental Fish to a Cornerstone of Scientific Discovery

Discover how zebrafish accelerate early-stage screening, enhance predictive insights, and reduce costs in drug development

Is the Traditional Drug Discovery Process Holding Back Your Pipeline?

The Impact of AI on Pipelines, Productivity, and Clinical Success

How Does ZeClinics Take Advantage of Data Science?

Leveraging Relationships in Knowledge Graphs to Enhance Drug Discovery and Target Identification

Key Mistakes to Avoid for Successful Zebrafish Genetic Modeling

Evaluating Methods for Precision and Efficiency in Genetic Engineering

Transgenic Animals Meaning + Application Examples

Two Applications of CRISPR/Cas9 Gene Knockout

Readily assess visual function in a live organism

Understanding DNA Repair Pathways

Harness the potential of our new Zebrafish-Based Platform for High-Throughput Gene Target Validation and Drug Screening in F0

The use of target gene-editing in preclinical research

The most precise CRISPR to date turns the genetic scissors into a Swiss army knife 

The United States approves technological alternatives to reduce animal testing

What is CRISPR technology and how can change our lives?

Gene editing enables scientists to alter the sequence of genes by adding, replacing, or removing certain DNA segments.

How does genetic information pass down through generations and what errors can occur?

The correspondence between two biological languages

What is the relationship between DNA, RNA and proteins?

Combining a zebrafish-based high throughput platform with artificial intelligence for human developmental toxicity assessment.

Zebrafish contribution to drug development reaching clinical stages

AI can address many challenges and limitations in traditional R&D and offer value in drug discovery in multiple ways.

Zebrafish for regulatory purposes in ecotoxicology and safety pharmacology

New trends and updated availability for zebrafish studies in EU and US

Why zebrafish can pave the way for investigating epilepsy’s etiology and screening new anti-seizure drugs

How to choose which type of experiment is best-suited for my research?

Use of biomarkers in endocrine disruption compounds screening and testing with zebrafish

Leveraging zebrafish to study Age-related Macular Degeneration

The emerging use of zebrafish to model metabolic diseases

Are zebrafish suitable for human drug discovery?

The regulatory status of zebrafish as an alternative preclinical model.

In ZeClinics we bet on emerging technologies to scale our solutions.

Zebrafish represents a key tool to boost drug discovery by enabling phenotypic screening approach in pharmacological-based disease models.

From challenge to knowledge: the outstanding performance of zebrafish in predicting toxicity.

ZeClinics can do it by using different genome editing approaches.

ZeClinics laboratory R&D efforts are mainly divided in the development of three research platforms including a number of research areas.

We knew the model was brilliant for academic research. Would it be as good for modeling human disease and discovering new drugs in an industrial setting?